0 Comment
by Kolapo Olapoju A new condom capable of deactivating 99.9 per cent of HIV, herpes and human papilloma virus cases has been designed – and it could be available for purchase within months, after key regulatory approval. Starpharma, an Australian bio-tech firm has developed the antiviral Viva Gel, the active ingredient designed to tackle sexually... Read More



